Arrhythmogenesis in Timothy Syndrome is associated with defects in Ca2+-dependent inactivation

Timothy Syndrome (TS) is a multisystem disorder, prominently featuring cardiac action potential prolongation with paroxysms of life-threatening arrhythmias. The underlying defect is a single de novo missense mutation in Ca V 1.2 channels, either G406R or G402S. Notably, these mutations are often vie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature communications 2016-01, Vol.7 (1), p.10370-12, Article 10370
Hauptverfasser: Dick, Ivy E., Joshi-Mukherjee, Rosy, Yang, Wanjun, Yue, David T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Timothy Syndrome (TS) is a multisystem disorder, prominently featuring cardiac action potential prolongation with paroxysms of life-threatening arrhythmias. The underlying defect is a single de novo missense mutation in Ca V 1.2 channels, either G406R or G402S. Notably, these mutations are often viewed as equivalent, as they produce comparable defects in voltage-dependent inactivation and cause similar manifestations in patients. Yet, their effects on calcium-dependent inactivation (CDI) have remained uncertain. Here, we find a significant defect in CDI in TS channels, and uncover a remarkable divergence in the underlying mechanism for G406R versus G402S variants. Moreover, expression of these TS channels in cultured adult guinea pig myocytes, combined with a quantitative ventricular myocyte model, reveals a threshold behaviour in the induction of arrhythmias due to TS channel expression, suggesting an important therapeutic principle: a small shift in the complement of mutant versus wild-type channels may confer significant clinical improvement. Timothy Syndrome (TS) is a multisystem disorder caused by two mutations leading to dysfunction of the Ca V 1.2 channel. Here, Dick et al . uncover a major and mechanistically divergent effect of both mutations on Ca 2+ /calmodulin-dependent inactivation of Ca V 1.2 channels, suggesting genetic variant-tailored therapy for TS treatment.
ISSN:2041-1723
2041-1723
DOI:10.1038/ncomms10370